Susan Clement Davies
Direktor/Vorstandsmitglied bei SCANCELL HOLDINGS PLC
Ursprung des Netzwerks ersten Grades von Susan Clement Davies
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 16 | |
MiNA Therapeutics Ltd.
 MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom.
8
| Holding Company | Biotechnology | 8 |
| Public Company | Medical/Nursing Services | 7 | |
| Public Company | Miscellaneous Commercial Services | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Susan Clement Davies
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| MEDISTEM INC | Medical Specialties | Chief Executive Officer Director/Board Member | |
Phase4 Partners Ltd.
 Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures ltd (Phase4 Ventures) is a venture capital subsidiary of Nomura International Plc founded in 1999. The firm is headquartered in London, UK. | Investment Managers | Director/Board Member | |
Bristol-Myers Squibb Pharmaceuticals Ltd.
 Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products are used for treatment of diseases like cancer, diabetes, arthritis, hepatitis, and psychiatric disorders. The company distributes products throughout the United Kingdom. Bristol-Myers Squibb Pharmaceuticals was founded in 1989 and is located in Uxbridge, UK. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Affibody AB
 Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Batu Biologics, Inc.
 Batu Biologics, Inc. Pharmaceuticals: MajorHealth Technology Batu Biologics, Inc. operates as an immunotherapy company. It develops therapeutics that addresses the multi-factorial and multi-dimensional nature of cancer. The company was founded by Samuel C. Wagner, Thomas Ichim and Dimitri Theofilopoulos and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Bath | College/University | Undergraduate Degree Undergraduate Degree | |
| GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| PROTEOME SCIENCES PLC | Medical Specialties | Director/Board Member Director/Board Member | |
| APTITUDE SOFTWARE GROUP PLC | Packaged Software | Director/Board Member Chairman | |
| TP GROUP PLC | Engineering & Construction | Director/Board Member Chairman | |
| University of Oxford | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
| Imperial College London | College/University | Corporate Officer/Principal Doctorate Degree | |
GlaxoSmithKline Biologicals NV
 GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| University of Cambridge | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Graduate Degree Undergraduate Degree | |
Benitec Biopharma Ltd.
 Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | Biotechnology | Director/Board Member Chief Operating Officer | |
Scancell Ltd.
 Scancell Ltd. Miscellaneous Commercial ServicesCommercial Services Scancell Ltd. researches and develops techniques for isolating foetal cells from a maternal blood sample. The company was founded by Lindy Durrant in 1997 and is headquartered in Nottingham, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Founder Chairman Chief Executive Officer Founder Director/Board Member | |
Sosei R&D Ltd.
 Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SYNGENE INTERNATIONAL LIMITED | Miscellaneous Commercial Services | Chief Executive Officer | |
| University of Plymouth | College/University | Director/Board Member | |
| Cranfield University | College/University | Masters Business Admin | |
| The University of Sheffield | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
| The University of Nottingham | College/University | Doctorate Degree Doctorate Degree Chairman Masters Business Admin | |
| University of Leicester | College/University | Doctorate Degree Doctorate Degree | |
| KROMEK GROUP PLC | Medical Specialties | Director/Board Member | |
| NXERA PHARMA CO., LTD. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Comptroller/Controller/Auditor | |
Heptares Therapeutics Ltd.
 Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Imperial College Healthcare NHS Trust
 Imperial College Healthcare NHS Trust Hospital/Nursing ManagementHealth Services Imperial College Healthcare NHS Trust is a non-profit organization which provides community and healthcare services. It offers cardiology, endocrinology, melanoma, maternity ultrasound, maternal medicine, and major trauma center. The organization was founded on October 1, 2007 and is headquartered in London, the United Kingdom. | Hospital/Nursing Management | Corporate Officer/Principal | |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
EMcision Ltd.
 EMcision Ltd. Medical SpecialtiesHealth Technology EMcision Ltd. develops medical devices. Its products include Habib EndoHPB, Endoblate, VesCoag, VesOpen, Percutaneous HPB, and EUS RFA. The firm's products are used for laparoscopic, vascular and endoscopic surgeries. It serves in the area of research and development and commercial sectors. The company was founded by Nagy Habib on June 16, 1999 and is headquartered in London, the United Kingdom. | Medical Specialties | Founder | |
| FRONTIER SMART TECHNOLOGIES GROUP LIMITED | Semiconductors | Chairman Director/Board Member | |
Evgen Ltd.
 Evgen Ltd. Medical/Nursing ServicesHealth Services Evgen Ltd. develops novel glucosinolate based products for the prevention and treatment of human disease. It engages in the clinical stage drug development that lead programmes are in breast cancer and subarachnoid haemorrhage, a type of stroke. Its activities also include carrying out preclinical work in multiple sclerosis and has a clinical interest in prostate cancer. The firm holds proprietary technology that enables sulforaphane to be synthesized and then subsequently stabilized for pharmaceutical application. The company was founded by Dr. Stephen Franklin on October 18, 2007 and is headquartered in Liverpool, the United Kingdom. | Medical/Nursing Services | Chairman Founder Director/Board Member | |
SmithKline Beecham Ltd.
 SmithKline Beecham Ltd. Pharmaceuticals: MajorHealth Technology Smithkline Beecham Ltd. manufacture of basic pharmaceutical products. It also provides mineral water, bottled water, and soft drinks. The company was founded on January 24, 1989 and is headquartered in Brentford, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| SIENNA CANCER DIAGNOSTICS LIMITED | Biotechnology | Director/Board Member Chief Executive Officer | |
Discuva Ltd.
 Discuva Ltd. Pharmaceuticals: MajorHealth Technology Discuva Ltd. develops antibiotics and drug-resistant pathogens. It is a drug discovery company focused on the creation of microbial against new emerging and drug-resistant bacterial pathogens. The company is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| Baines Peter Consulting | Director/Board Member | ||
| Middlesex University Business School | College/University | Masters Business Admin | |
| UCL Medical School | College/University | Doctorate Degree | |
| Coma Research Institue | Director/Board Member | ||
| CLARITY PHARMACEUTICALS LTD | Medical Specialties | Director/Board Member | |
| Newstar Ventures Ltd. | Founder Director/Board Member | ||
Deepbridge Capital LLP
 Deepbridge Capital LLP Investment ManagersFinance Deepbridge Capital LLP (Deepbridge) is an investment management firm founded in 2010. The firm is headquartered in Chester, UK. | Investment Managers | Consultant / Advisor Investment Committee Member | |
| Royal Free Hospital Medical School | College/University | Doctorate Degree | |
Mina (Holdings) Ltd.
 Mina (Holdings) Ltd. Financial ConglomeratesFinance Mina (Holdings) Ltd. is an investment holding British company founded in 2014. The private company is based in London, UK. The company's main function is to hold investments. | Financial Conglomerates | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
University of Plymouth Enterprise Ltd.
 University of Plymouth Enterprise Ltd. Miscellaneous Commercial ServicesCommercial Services Part of University of Plymouth, University of Plymouth Enterprise Ltd. engages in exploitation of assets and intellectual property. The company is based in Plymouth, UK. It was founded in 1999. | Miscellaneous Commercial Services | Director/Board Member |
Statistik
International
| Vereinigtes Königreich | 33 |
| Vereinigte Staaten | 7 |
| Australien | 6 |
| Indien | 4 |
| Schweden | 2 |
Sektoral
| Health Technology | 22 |
| Consumer Services | 13 |
| Commercial Services | 6 |
| Finance | 4 |
| Health Services | 3 |
Operativ
| Director/Board Member | 193 |
| Corporate Officer/Principal | 58 |
| Chairman | 47 |
| Chief Executive Officer | 36 |
| Independent Dir/Board Member | 28 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Alan J. Lewis | 33 |
| John Chiplin | 26 |
| Barry Clare | 25 |
| Peter Bertram | 21 |
| Jean-Michel Cossery | 21 |
| Peter Bains | 19 |
| Robert Kopple | 18 |
| Gur Roshwalb | 17 |
| Christopher Barry Wood | 16 |
| Ursula Ney | 16 |
| Martyn Ratcliffe | 15 |
| Marc d'Abbadie | 13 |
| Robert Matthew Miller | 10 |
| Cliff Holloway | 9 |
| Charles O'Bryan-Tear | 9 |
- Börse
- Insiders
- Susan Clement Davies
- Unternehmensverbindungen
